New EU-funded Consortium to Develop Fully Personalized Cancer Vaccines

News   Jul 05, 2013

 
New EU-funded Consortium to Develop Fully Personalized Cancer Vaccines
 
 
 
 

RELATED ARTICLES

CRISPR Used to Prevent Development of Angiogenesis of the Retina

News

Powerful new technology may lead to novel therapies to prevent vision loss, blindness in those with diseases of the retina.

READ MORE

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News

TheFDA has changed its accelerated approval of blinatumomab (Blincyto®) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE